Surveillance HeartCare® Outcomes Registry

Overview

About this study

The purpose of this study is to assess the clinical utility of surveillance using HeartCare testing services, in association with clinical care of heart transplant recipients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients who are ≥ 15 years of age at the time of blood draw.
  • Received a heart transplant (primary or repeat).
  • Patients who have HeartCare initiated within 3 months post-transplant.

Exclusion Criteria:

  • Patients who are pregnant at the time of blood draw.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Alfredo Clavell, M.D.

Closed for enrollment

Contact information:

Julie Gecox Hanson CCRP

(507) 293-6592

Gecox.Julie@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Juan Carlos Leoni Moreno, M.D.

Closed for enrollment

Contact information:

Angela Casini MFA

Casini.Angela@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

David Steidley, M.D.

Closed for enrollment

Contact information:

Julieta Williams

(480) 342-1785

Williams.Julieta@mayo.edu

More information

Publications

Publications are currently not available